Zobrazeno 1 - 10
of 141
pro vyhledávání: '"luminal B breast cancer"'
Autor:
Rusen Cosar, Necdet Sut, Sule Parlar, Yıldıray Ozguven, Dilek Nurlu, Ebru Tastekin, Sena Batu, Eylül Şenödeyici, Talar Ozler, Melisa Dedeli, Gökay Yıldız, Sekip Kavukcu, Mert Chousein, Zeynep Alas, Sernaz Topaloglu
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Breast cancer has been a disease in which treatment strategy has changed over time under the influence of different hypotheses and evidence for more than a century. We analyzed the contribution of radiotherapy to disease-free surv
Externí odkaz:
https://doaj.org/article/33ece13d11a04f1b9b5d21290b41e2ca
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Breast cancer (BC) is the most common malignancy in women and the second leading cause of cancer-related death; chemoresistance is still a clinical challenge mainly because of the different molecular features of this kind of tumou
Externí odkaz:
https://doaj.org/article/9fc89e9a3a1f4ec48ea0da5ee2484071
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8278-8288 (2023)
Abstract The importance of the immune microenvironment in triple negative and HER2‐amplified breast cancer (BC) is well‐established; less is known about the immune environment in luminal breast cancers. We aimed to assess for the impact of immune
Externí odkaz:
https://doaj.org/article/10b3700d6bc843a7ba23ff71e8df4db4
Autor:
Valentina Camargo-Herrera, Giovanny Castellanos, Nelson Rangel, Guillermo Antonio Jiménez-Tobón, María Martínez-Agüero, Milena Rondón-Lagos
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4478 (2024)
Chromosomal instability (CIN), defined by variations in the number or structure of chromosomes from cell to cell, is recognized as a distinctive characteristic of cancer associated with the ability of tumors to adapt to challenging environments. CIN
Externí odkaz:
https://doaj.org/article/cb6115f7b0e944769db9ed2e6e4cce2a
Autor:
Jaynish S. Shah, Michael J. G. Milevskiy, Veronika Petrova, Amy Y. M. Au, Justin J. L. Wong, Jane E. Visvader, Ulf Schmitz, John E. J. Rasko
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-11 (2022)
Abstract Background After many years of neglect in the field of alternative splicing, the importance of intron retention (IR) in cancer has come into focus following landmark discoveries of aberrant IR patterns in cancer. Many solid and liquid tumour
Externí odkaz:
https://doaj.org/article/683ffd8de71f4bcaa4fcd67ff3102fbf
Autor:
Cosar R, Sut N, Ozen A, Tastekin E, Topaloglu S, Cicin I, Nurlu D, Ozler T, Demir S, Yıldız G, Şenödeyici E, Uzal MC
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 14, Pp 259-280 (2022)
Rusen Cosar,1 Necdet Sut,2 Alaattin Ozen,3 Ebru Tastekin,4 Sernaz Topaloglu,5 Irfan Cicin,5 Dilek Nurlu,1 Talar Ozler,1 Seda Demir,1 Gokay Yıldız,1 Eylül Şenödeyici,6 Mustafa Cem Uzal7 1Department of Radiation Oncology, Trakya University Faculty
Externí odkaz:
https://doaj.org/article/b5a2cdd68a944cfda54ac48c1eceaee2
Autor:
Zhuo Zhang, Hanxu Zhang, Chao Li, Qian Xiang, Ling Xu, Qianxin Liu, Xiaocong Pang, Wenjia Zhang, Hong Zhang, Shuang Zhang, Xuening Duan, Yinhua Liu, Yimin Cui
Publikováno v:
Thoracic Cancer, Vol 12, Iss 24, Pp 3396-3406 (2021)
Abstract Purpose Circulating microRNAs (miRNAs) have been indicated as predictive biomarker for the response to neoadjuvant chemotherapy (NAC) and the prognosis of breast cancer (BC); however, to date the conclusions have been controversial. The biol
Externí odkaz:
https://doaj.org/article/0a1dc5df9c1d40c689b878e4eae9b55e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alex De Caluwé, Laurence Buisseret, Philip Poortmans, Dirk Van Gestel, Roberto Salgado, Christos Sotiriou, Denis Larsimont, Marianne Paesmans, Ligia Craciun, Drisis Stylianos, Christophe Vandekerckhove, Fabien Reyal, Veys Isabelle, Daniel Eiger, Martine Piccart, Emanuela Romano, Michail Ignatiadis
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Residual breast cancer after neo-adjuvant chemotherapy (NACT) predicts disease outcome and is a surrogate for survival in aggressive breast cancer (BC) subtypes. Pathological complete response (pCR) rate, however, is lower for lum
Externí odkaz:
https://doaj.org/article/77e1e848595f46df8edd12cb7e91b490
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.